Correction of a mouse model of sickle cell disease:: Lentiviral/anti-sickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells.

被引：0
|
作者：
Levasseur, DN [1 ]
Ryan, TM [1 ]
Pawlik, KM [1 ]
Townes, TM [1 ]
机构：
[1] Univ Alabama, Birmingham, AL USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2736
引用
收藏
页码：741A / 742A
页数：2
相关论文
共 50 条
  • [1] Correction of a mouse model of sickle cell disease:: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells
    Levasseur, DN
    Ryan, TM
    Pawlik, KM
    Townes, TM
    [J]. BLOOD, 2003, 102 (13) : 4312 - 4319
  • [2] Correction of sickle cell disease in a transgenic mouse model by lentiviral transduction of unmobilized and purified hematopoietic stem cells.
    Levasseur, DN
    Ryan, TM
    Townes, TM
    [J]. BLOOD, 2002, 100 (11) : 443A - 443A
  • [3] High level and persistent expression of an anti-sickling β-globin gene after lentiviral-mediated transduction of human hematopoietic stem cells
    Imren, S
    Karen, WA
    Fabry, ME
    Pawliuk, R
    Tang, P
    Reid, D
    Nagel, RL
    Leboulch, P
    Humphries, RK
    Eaves, CJ
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S406 - S407
  • [4] Lentiviral transduction of unmobilized, purified HSCs: Correction of sickle cell disease in mice.
    Levasseur, DN
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2003, 31 (01) : 151 - 151
  • [5] Treatment of sickle cell disease with anti-sickling gene therapy
    Van Raamsdonk, J
    [J]. CLINICAL GENETICS, 2002, 61 (04) : 258 - 260
  • [6] Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
    Poletti, Valentina
    Urbinati, Fabrizia
    Charrier, Sabine
    Corre, Guillaume
    Hollis, Roger P.
    Fernandez, Beatriz Campo
    Martin, Samia
    Rothe, Michael
    Schambach, Axel
    Kohn, Donald B.
    Mavilio, Fulvio
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 11 : 167 - 179
  • [7] Pre-clinical development of a lentiviral vector expressing the anti-sickling βAS3 globin for gene therapy for sickle-cell disease
    Poletti, V.
    Charrier, S.
    Urbinati, F.
    Hollis, R. P.
    Corre, G.
    Martin, S.
    Weber, L.
    Rothe, M.
    Schambach, A.
    Miccio, A.
    Cavazzana, M.
    Kohn, D. B.
    Mavilio, F.
    [J]. HUMAN GENE THERAPY, 2017, 28 (12) : A17 - A18
  • [8] β-Globin Locus Control Region Core Sequences Driving Expression of Anti-Sickling Globin Ameliorates Disease Phenotype in a Mouse Model of Sickle Cell Disease
    Morgan, Richard A.
    Unti, Mildred
    Hollis, Roger P.
    Kohn, Donald B.
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 322 - 323
  • [9] Expression of an anti-sickling β-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells
    Oh, IH
    Fabry, ME
    Humphries, RK
    Pawliuk, R
    Leboulch, P
    Hoffman, R
    Nagel, RL
    Eaves, C
    [J]. EXPERIMENTAL HEMATOLOGY, 2004, 32 (05) : 461 - 469
  • [10] Characterization of an anti-sickling hemoglobin for gene therapy of sickle cell disease.
    Reilly, MP
    McCune, S
    Townes, TM
    Asakura, T
    [J]. BLOOD, 1995, 86 (10) : 1655 - 1655
12345